Câncer do colo
Tipos de rastreamento
Palavras-chave:
rastreamento, câncer cervical, teste de DNA, exame de PapanicolaouReferências
Instituto Nacional de Câncer José Alencar Gomes da Silva. Estimativa 2023: incidência de câncer no Brasil. Rio de Janeiro: 2023. 162 p.
Hoda RS, Loukeris K, Abdul-Karim FW. Gynecologic cytology on conventional and liquid-based preparations: a comprehensive review of similarities and differences. Diagn Cytopathol. 2013; 41(3):257-78
Arbyn M, Bergeron C, Klinkhamer P, Martin-Hirsch P,Siebers AG, Bulten J. Liquid compared with conventional cervical cytology: A systematic review and meta-analysis. ObstetGynecol 2008; 111:167–77.
Instituto Nacional de Câncer José Alencar Gomes da Silva. Diretrizes brasileiras para o rastreamento do câncer do colo do útero. 2. ed. rev. atual. – Rio de Janeiro: INCA, 2016. 114p.
Wright T, Stoler MH, Behrens CM, Sharma A, Zhang G, Whirgt TL. Primary cervical cancer screening with human papilomavírus: end of study results from the ATHENA study using HPV as the first-line screening test. Gynecol Oncol. 2015; 136:189-97.
Federação Brasileira das Associações de Ginecologia e Obstetrícia (Febrasgo). Speck NMG, Carvalho JP. Dossiê de estratégias do rastreamento do câncer de colo uterino no Brasil. 2018. Disponível em htpp://febrasgo.com.br.
Bonde JH, Jesper H.; Sandri, Maria-Teresa; Gary, Devin S.; Andrews, Jeffrey C. Clinical Utility of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Systematic Review. JLGTD 2020;24(1):1-13.
Arbyn M, Smith SB, Temin S, Sultana F, Castle P. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses. BMJ 2018;363:k4823.
World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva: World Health Organization; 2020. Disponível em: https://www. who.int/publications/i/item/9789240014107.
